Belatacept Immunosuppression in High Risk Liver Transplant Recipients

被引：0
|
作者：
Masters, Brian M. [1 ,2 ]
Sparkes, Tracy M. [1 ,2 ]
Hanish, Steven I. [2 ]
Potosky, Darryn R. [2 ]
Hutson, William R. [2 ]
Barth, Rolf N. [2 ]
LaMattina, John C. [2 ]
机构：
[1] Univ Maryland, Med Ctr, Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Transplant, Baltimore, MD 21201 USA
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-473
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [31] Utilization and clinical outcomes of belatacept- based immunosuppression in US renal transplant recipients
    Wen, Xuerong
    JinCasey, Michael
    Santos, Alfonso H.
    Hartzema, Abraham
    Womer, Karl
    TRANSPLANTATION, 2016, 100 (07) : S81 - S81
  • [32] Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
    Kirk, Allan D.
    Adams, Andrew B.
    Durrbach, Antoine
    Ford, Mandy L.
    Hildeman, David A.
    Larsen, Christian P.
    Vincenti, Flavio
    Wojciechowski, David
    Woodle, E. Steve
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (05) : 1691 - 1698
  • [33] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [34] Belatacept reduces skin cancer risk in kidney transplant recipients
    Wang, Mike
    Mittal, Amit
    Colegio, Oscar R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 996 - 998
  • [35] Feasibility of TruGraf® liver for personalized immunosuppression in liver transplant recipients
    Moaddab, M.
    Mobley, C. M.
    Saharia, A.
    Connor, A. A.
    Hobeika, M.
    Simon, C. J.
    Cheah, Y. L.
    Brombosz, E. W.
    Moore, L. W.
    Victor, D. W., III
    Kodali, S.
    Gaber, A. O.
    Ghobrial, R. M.
    LIVER TRANSPLANTATION, 2024, 30 : 168 - 169
  • [36] Transient Utilization of Belatacept Facilitates Renal Recovery in Liver Transplant Recipients
    Masters, B.
    Sparkes, T.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    LaMattina, J.
    Barth, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 753 - 754
  • [37] Withdrawal of immunosuppression in liver transplant recipients: Is this as good as it gets?
    McCaughan, GW
    LIVER TRANSPLANTATION, 2002, 8 (04) : 408 - 410
  • [38] Weaning of immunosuppression in living donor liver transplant recipients
    Takatsuki, M
    Uemoto, S
    Inomata, Y
    Egawa, H
    Kiuchi, T
    Fujita, S
    Hayashi, M
    Kanematsu, T
    Tanaka, K
    TRANSPLANTATION, 2001, 72 (03) : 449 - 454
  • [39] Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients
    Shaker, T.
    Ramanathan, K.
    Riad, S.
    Vock, D.
    Chinnakotla, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 511 - 512
  • [40] Everolimus-Based Immunosuppression in Liver Transplant Recipients
    Saliba, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2489 - 2489
12345